Glaucoma Surgery Market Anticipated to Surpass its Previous Valuation by 2023

Market Overview:

The global Glaucoma Surgery Market was analyzed by Market Research Future (MRFR) and it was projected that a healthy CAGR of 7.9% will be attained by the market over the forecast period of 2018 to 2023. The valuation of the glaucoma surgery market was further stated to surpass its previous valuation by the end of the forecast period.

Glaucoma refers to a particular disease that affects the eyesight of a person and can even cause blindness. It is a highly dangerous disease and usually considered as a chronic illness. This disease is mostly found in elderly people and is a result of aging. Other causes of glaucoma can be diabetes or deficiency of certain vitamins in the body. The number of glaucoma patients has risen sharply in recent times across the world and good surgeons are the immediate need for catering to such patients.

Currently every large healthcare brand can be seen investing largely in expanding their glaucoma surgery capabilities. The highest rate of Glaucoma can be found in older people in the Middle East and African regions, closely followed by Europe. The North American countries and Asia Pacific regions are also major hubs of this disease. There are various kinds of surgeries that can be performed in order to get rid of Glaucoma.

Competitive Landscape:

·         Bausch & Lomb

·         Pfizer

·         Santen

·         Allergan

·         Merck & Co

·         Abbott

·         Ellex Medical Lasers

·         Lumenis

·         Novartis AG

·         Akor

·         Pharmaceuticals

Market Segmentation:

·         The global glaucoma surgery market has been segmented in terms of type of surgery, end-user, and target.

·         By target, the market divides into suprachoroidal space, trabecular meshwork, and others.

·         By type of surgery, the market segments into laser surgery, angle closure glaucoma surgery, aqueous shunt surgery, and other.

·         By end user, the market comprises into hospital, ambulatory surgery centers and other.

Regional Analysis:

The global glaucoma surgery market size is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East & Africa.

The global glaucoma surgery market share is spearheaded by North America with the highest percentage of shares. This is due to the massive population herein that is suffering from diseases like diabetes and other critical eye diseases. The rising level of healthcare expenditure and enhanced infrastructure also has an influencing impact on the growth of the regional market.

Europe stands out as the second largest glaucoma surgery regional market Overview followed by Asia Pacific. In Asia Pacific, the presence of a huge population base and fast paced development in healthcare industry has helped attract a number of companies to develop there market in Asia Pacific region, thereby boosting the growth herein.

Elsewhere, the Asia Pacific market is expected to grow at a consistent pace. The region is reported to become a key market area for glaucoma surgeries in the coming years with the increasing prevalence of the disease and advancing healthcare technologies.